Silicon Laboratories Inc.
SLAB
$128.77
-$3.00-2.28%
NASDAQ
| 04/05/2025 | 12/28/2024 | 09/28/2024 | 06/29/2024 | 03/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 655.73M | 584.39M | 504.98M | 542.35M | 641.85M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 655.73M | 584.39M | 504.98M | 542.35M | 641.85M |
| Cost of Revenue | 300.83M | 272.20M | 239.09M | 247.74M | 280.05M |
| Gross Profit | 354.90M | 312.19M | 265.89M | 294.60M | 361.80M |
| SG&A Expenses | 153.54M | 145.45M | 142.67M | 133.65M | 135.66M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 794.16M | 749.88M | 714.96M | 710.40M | 744.71M |
| Operating Income | -138.44M | -165.49M | -209.97M | -168.05M | -102.86M |
| Income Before Tax | -126.47M | -154.81M | -214.23M | -173.99M | -105.20M |
| Income Tax Expenses | 38.48M | 36.20M | 22.75M | 24.13M | -195.00K |
| Earnings from Continuing Operations | -164.95 | -191.01 | -236.97 | -198.12 | -105.01 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -164.95M | -191.01M | -236.97M | -198.12M | -105.01M |
| EBIT | -138.44M | -165.49M | -209.97M | -168.05M | -102.86M |
| EBITDA | -90.88M | -116.91M | -160.15M | -117.00M | -51.81M |
| EPS Basic | -5.11 | -5.95 | -7.40 | -6.19 | -3.29 |
| Normalized Basic EPS | -2.45 | -3.01 | -4.19 | -3.40 | -2.06 |
| EPS Diluted | -5.12 | -5.95 | -7.41 | -6.21 | -3.32 |
| Normalized Diluted EPS | -2.45 | -3.01 | -4.19 | -3.41 | -2.08 |
| Average Basic Shares Outstanding | 129.32M | 128.76M | 128.19M | 127.68M | 127.17M |
| Average Diluted Shares Outstanding | 129.32M | 128.76M | 128.19M | 127.96M | 128.76M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |